Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.

ABSTRACT:

Background

Patients with end-stage renal disease (ESRD) receiving dialysis have been reported to have increased risk of cancer. However, contemporary cancer burden estimates in this population are sparse and do not account for the high competing risk of death characteristic of dialysis patients.

Study design

Retrospective cohort study.

Setting & participants

US adult patients enrolled in Medicare's ESRD program who received in-center hemodialysis.

Factors

Demographic/clinical characteristics.

Outcomes

For overall and site-specific cancers identified using claims-based definitions, we calculated annual incidence rates (1996-2009). We estimated 5-year cumulative incidence since dialysis therapy initiation using competing-risk methods.

Results

We obs

SUBMITTER: Butler AM 

PROVIDER: S-EPMC4924349 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature